Cargando…

Therapeutic effect of interleukin 12 on mouse haemangiosarcomas is not associated with an increased anti-tumour cytotoxic T-lymphocyte activity.

In syngeneic mice, the H5V polyoma middle-T oncogene-transformed endothelioma cell line induces Kaposi's sarcoma-like cavernous haemangiomas that regress transiently, probably because of an anti-tumour immune response, but eventually grow progressively and kill the host. To evaluate the generat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vizler, C., Rosato, A., Calderazzo, F., Quintieri, L., Fruscella, P., Wainstok de Calmanovici, R., Mantovani, A., Vecchi, A., Zanovello, P., Collavo, D.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1998
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2149920/ https://www.ncbi.nlm.nih.gov/pubmed/9484826

Ejemplares similares

Delivery of methoxymorpholinyl doxorubicin by interleukin 2-activated NK cells: effect in mice bearing hepatic metastases
por: Quintieri, L, et al.
Publicado: (1999)

Lingual haemangiosarcoma in a crossbred dog
por: Owen, Laura J, et al.
Publicado: (2006)

Temporary inhibition of Moloney-murine sarcoma virus (M-MSV) induced-tumours by adoptive transfer of ricin-treated T-lymphocytes.
por: Cerundolo, V., et al.
Publicado: (1987)

Spinal cord haemangiosarcoma in one dog – Case report
por: Kuricova, Maria, et al.
Publicado: (2023)

Haemangiosarcoma in a captive Asiatic lion (Panthera leo persica)
por: Vercammen, F., et al.
Publicado: (2015)

Use of metronomic chemotherapy in the management of a cat with abdominal haemangiosarcoma
por: Yee-Ka Cheng, Katrina, et al.
Publicado: (2018)

Equine conjunctival haemangiosarcoma: Clinical presentation, management, and outcome of seven cases in the United Kingdom
por: Kashani-Carver, Andrea, et al.
Publicado: (2023)

Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumours
por: Iacovazzo, Donato, et al.
Publicado: (2019)

Influence of tumour physico-chemical conditions on interleukin-2-stimulated lymphocyte proliferation.
por: Loeffler, D. A., et al.
Publicado: (1992)

Effects of Interleukin‐12 on the Induction of Cytotoxic T Lymphocytes from the Regional Lymph Node Lymphocytes of Patients with Lung Adenocarcinoma
por: Hanagiri, Takeshi, et al.
Publicado: (1998)

In vitro and in vivo evaluation of T and B lymphocyte functions in AKR mice.
por: Collavo, D., et al.
Publicado: (1975)

Inhibitory effect of YC8 leukaemia cell line on in vitro lymphocyte reactivity.
por: Biasi, G., et al.
Publicado: (1977)

Interleukin‐12 Augments the Generation of Autologous Tumor‐reactive CD8(+) Cytotoxic T Lymphocytes from Tumor‐infiltrating Lymphocytes
por: Kuge, Soichi, et al.
Publicado: (1995)

Direct Activation of Human CD8(+) Cytotoxic T Lymphocytes by Interleukin‐18
por: Kohyama, Masako, et al.
Publicado: (1998)

Interleukin 1 and tumour necrosis factor alpha may be responsible for the lytic mechanism during anti-tumour antibody-dependent cell-mediated cytotoxicity.
por: Pullyblank, A. M., et al.
Publicado: (1995)

Matrix Metalloproteinases in Cytotoxic Lymphocytes Impact on Tumour Infiltration and Immunomodulation
por: Edsparr, Karin, et al.
Publicado: (2010)

Cytotoxic lymphocyte maturation factor (interleukin 12) is a synergistic growth factor for hematopoietic stem cells
Publicado: (1993)

Clonal and functional analysis for the augmentation of tumour-infiltrating lymphocytes by interleukin 4.
por: Tsunoda, T., et al.
Publicado: (1996)

Induction of tumour-specific CD8(+) cytotoxic T lymphocytes by tumour lysate-pulsed autologous dendritic cells in patients with uterine serous papillary cancer
por: Santin, A D, et al.
Publicado: (2002)

Targeted calcium influx boosts cytotoxic T lymphocyte function in the tumour microenvironment
por: Kim, Kyun-Do, et al.
Publicado: (2017)

Characterization of antigen-presenting properties of tumour cells using virus-specific cytotoxic T lymphocytes
por: Spierings, D C J, et al.
Publicado: (2000)

Localized interleukin-12 delivery for immunotherapy of solid tumours
por: Wei, Louis Z, et al.
Publicado: (2013)

Peripheral Helper Lymphocytes Produce Interleukin 12 in Cancer Patients
por: Michelin, Márcia A., et al.
Publicado: (2013)

Interleukin 4 promotes the growth of tumor-infiltrating lymphocytes cytotoxic for human autologous melanoma
Publicado: (1988)

Serum levels of soluble interleukin-2 receptors and their relation to lymphocyte subpopulations in patients with metastatic solid tumours.
por: Lissoni, P., et al.
Publicado: (1989)

Tumour cell products inhibit both functional and immunoreactive interleukin 2 production by human blood lymphocytes.
por: Nelson, M., et al.
Publicado: (1989)

Effects of interleukin-2 and interferon-alpha A/D treatment on lymphocytes from tumour-bearing mice.
por: Ligo, M., et al.
Publicado: (1989)

Generation of Tumor-associated Cytotoxic T Lymphocytes Requires Interleukin 4 from CD8(+) T Cells
por: Schüler, Thomas, et al.
Publicado: (2001)

A Pivotal Role for Interleukin-27 in CD8(+) T Cell Functions and Generation of Cytotoxic T Lymphocytes
por: Morishima, Noriko, et al.
Publicado: (2010)

The Suppressed Induction of Human Mature Cytotoxic T Lymphocytes Caused by Asbestos Is Not due to Interleukin-2 Insufficiency
por: Kumagai-Takei, Naoko, et al.
Publicado: (2016)

Restored T-cell activation mechanisms in human tumour-infiltrating lymphocytes from melanomas and colorectal carcinomas after exposure to interleukin-2
por: De Paola, F, et al.
Publicado: (2003)

Alloimmune cells consume interleukin-2 and competitively inhibit the anti-tumour effects of interleukin-2.
por: Eggermont, A. M., et al.
Publicado: (1987)

Induction of interleukin 12 responsiveness is impaired in anergic T lymphocytes
Publicado: (1994)

Tumour-induced changes in murine lymphocyte profiles.
por: Matossian-Rogers, A., et al.
Publicado: (1982)

Activation of K cells in mice with transplanted tumours differing in immunogenicity and metastasizing capacity.
por: Mantovani, A., et al.
Publicado: (1977)

Interleukin 7 generates antitumor cytotoxic T lymphocytes against murine sarcomas with efficacy in cellular adoptive immunotherapy
Publicado: (1991)

Interleukin 7 promotes long-term in vitro growth of antitumor cytotoxic T lymphocytes with immunotherapeutic efficacy in vivo
Publicado: (1994)

Cytotoxicity of lymphocytes from blood, tumour and regional lymph nodes against K562 cells and autoplastic colorectal tumour cells.
por: Hutchinson, G. H., et al.
Publicado: (1982)

Comparison of the potential therapeutic effects of interleukin 2 or interleukin 4 secretion by a single tumour.
por: Patel, P. M., et al.
Publicado: (1993)

Expression of MHC class II, interleukin 2 receptor and CD45 antigens on tumour-associated T lymphocytes in colonic carcinoma.
por: Norazmi, M. N., et al.
Publicado: (1989)

Cannot write session to /tmp/vufind_sessions/sess_vv59kst6vv3cle5cgmm1mbouqn